Abiopharma

IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights

ORIC® Pharmaceuticals Announces Publication in Cancer Research on the Discovery and Development of Enozertinib, a Highly Selective, Brain-Penetrant EGFR Inhibitor

Denali Therapeutics Announces Board and Executive Leadership Updates

Notification from Tenax Therapeutics

BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

Novo Nordisks CagriSema associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®

Auxly to Report Third Quarter 2025 Results on November 13, 2025

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans

Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Baxter International